BRIEF-Idera Pharmaceuticals presents positive translational and clinical data update from ongoing IMO-2125 development program
November 09, 2017 at 07:58 AM EST
* Idera Pharmaceuticals Inc presents positive translational and clinical data update from ongoing IMO-2125 development program at the 2017 society for immunotherapy of cancer annual meeting (SITC)
